↓ Skip to main content

Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis

Overview of attention for article published in Cochrane database of systematic reviews, July 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

blogs
2 blogs
twitter
8 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
26 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis
Published in
Cochrane database of systematic reviews, July 2023
DOI 10.1002/14651858.cd011585.pub2
Pubmed ID
Authors

Harry D Zacharias, Fady Kamel, Jaclyn Tan, Nina Kimer, Lise Lotte Gluud, Marsha Y Morgan

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 26 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 4 15%
Student > Bachelor 3 12%
Researcher 3 12%
Student > Doctoral Student 3 12%
Student > Ph. D. Student 2 8%
Other 4 15%
Unknown 7 27%
Readers by discipline Count As %
Medicine and Dentistry 7 27%
Unspecified 4 15%
Nursing and Health Professions 2 8%
Agricultural and Biological Sciences 1 4%
Economics, Econometrics and Finance 1 4%
Other 3 12%
Unknown 8 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 March 2024.
All research outputs
#1,819,100
of 25,707,225 outputs
Outputs from Cochrane database of systematic reviews
#3,877
of 13,137 outputs
Outputs of similar age
#32,610
of 365,625 outputs
Outputs of similar age from Cochrane database of systematic reviews
#36
of 142 outputs
Altmetric has tracked 25,707,225 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,137 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,625 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 142 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.